Akshay Mahesh Shah, MD
Neurology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 8 carriers
- Office
- 1
Offices
1 location · San Jose Pacific Neurology Cntr Prof Cor · 3 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
33 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shah’s office at (408) 347-1600 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A129993 · Current
Licensed to practise in California · since 2014 · expires 2027-08-31 · Bhavnagar University, Government Medical College Bhavnagar.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$114,763
Medicare paid this office $114,763 for 613 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 300 | $43,355 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 118 | $12,074 | $102 |
| New patient visit (45+ min) | 100 | $11,561 | $116 |
| Short return visit (20+ min) | 93 | $7,111 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $7,048 | $63 |
See all 11 services
| Return visit (30+ min) | 300 | $43,355 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 118 | $12,074 | $102 |
| New patient visit (45+ min) | 100 | $11,561 | $116 |
| Short return visit (20+ min) | 93 | $7,111 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $7,048 | $63 |
| Critical care, first 30-74 minutes | 40 | $6,635 | $166 |
| Muscle electrical test | 20 | $5,575 | $90 |
| Nerve test | 15 | $3,874 | $258 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,690 | $141 |
| Measurement of brain wave activity (eeg), awake and drowsy | 24 | $1,126 | $45 |
| Measurement of brain wave activity (eeg), awake and asleep | 12 | $563 | $47 |
Who their Medicare patients are
613 Original Medicare patients in 2024. Average age 75 · Under 65 12% · 85 and older 22% · Women 54% · Also on Medicaid 60% · Health risk score 1.73. Above the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Diabetes 51% · Stroke 38% · Dementia 31% · Coronary heart disease 30% · Chronic kidney disease 30% · Depression 27% · Heart failure 23% · Atrial fibrillation 23% · COPD 15% · Cancer 11%.
The office billed $464,851, Medicare allowed $162,027 and paid $114,763; for 1,612 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 613 | 1,612 | 75 | 1.73 | $464,851 | $114,763 |
| 2023 | 468 | 982 | 75 | 1.85 | $189,753 | $92,715 |
| 2022 | 553 | 998 | 75 | 1.98 | $174,595 | $114,448 |
| 2021 | 470 | 1,862 | 75 | 1.82 | $174,345 | $124,788 |
| 2020 | 422 | 1,241 | 74 | 1.95 | $121,107 | $91,693 |
| 2019 | 469 | 3,164 | 75 | 1.79 | $176,569 | $126,141 |
| 2018 | 542 | 5,271 | 74 | 2.00 | $236,528 | $167,925 |
| 2017 | 464 | 3,521 | 74 | 1.99 | $170,277 | $121,621 |
| 2016 | 415 | 1,904 | 74 | 1.92 | $168,583 | $123,278 |
| 2015 | 235 | 609 | 74 | 1.78 | $80,900 | $60,117 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 232 | $33,842 | $112 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 88 | $9,963 | $113 |
| New patient visit (45+ min) | 57 | $8,253 | $145 |
| Critical care, first 30-74 minutes | 37 | $7,125 | $188 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $6,273 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $6,135 | $67 |
| Nerve test | 17 | $4,881 | $287 |
| Muscle electrical test | 17 | $3,868 | $99 |
| Measurement of brain wave activity (eeg), awake and asleep | 33 | $1,722 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,530 | $96 |
| Measurement of brain wave activity (eeg), awake and drowsy | 11 | $574 | $48 |
2022: 11 services
| Return visit (30+ min) | 287 | $50,078 | $112 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 134 | $16,204 | $121 |
| New patient visit (45+ min) | 98 | $14,369 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $8,074 | $65 |
| Critical care, first 30-74 minutes | 28 | $6,059 | $195 |
| Nerve test | 11 | $3,212 | $292 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,156 | $180 |
| Muscle electrical test | 17 | $1,902 | $106 |
| Measurement of brain wave activity (eeg), awake and drowsy | 25 | $1,442 | $53 |
| Muscle electrical test | 14 | $979 | $70 |
| Measurement of brain wave activity (eeg), awake and asleep | 15 | $809 | $54 |
2021: 13 services
| Return visit (30+ min) | 237 | $52,019 | $114 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 131 | $15,914 | $120 |
| New patient visit (45+ min) | 92 | $13,346 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $9,027 | $65 |
| Critical care, first 30-74 minutes | 29 | $5,935 | $198 |
| Nerve test | 12 | $3,565 | $297 |
| Muscle electrical test | 25 | $3,018 | $108 |
| Nerve test | 13 | $2,530 | $195 |
| Muscle electrical test | 22 | $1,738 | $72 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,312 | $69 |
| Measurement of brain wave activity (eeg), awake and asleep | 20 | $1,062 | $53 |
| Measurement of brain wave activity (eeg), awake and drowsy | 18 | $977 | $54 |
| Short return visit (20+ min) | 13 | $679 | $52 |
2020: 11 services
| Return visit (30+ min) | 216 | $34,553 | $103 |
| New patient visit (45+ min) | 91 | $14,076 | $155 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 85 | $10,970 | $128 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $7,705 | $68 |
| Telephone medical discussion with physician, 11-20 minutes | 57 | $3,736 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,482 | $177 |
| Critical care, first 30-74 minutes | 11 | $2,421 | $202 |
| Muscle electrical test | 14 | $1,525 | $102 |
| Muscle electrical test | 15 | $1,420 | $68 |
| Measurement of brain wave activity (eeg), awake and drowsy | 15 | $940 | $55 |
| Short return visit (20+ min) | 15 | $886 | $55 |
2019: 9 services
| Return visit (30+ min) | 301 | $53,808 | $94 |
| New patient visit (45+ min) | 141 | $19,209 | $136 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 70 | $8,742 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $5,648 | $66 |
| Nerve test | 17 | $3,067 | $180 |
| Muscle electrical test | 23 | $2,636 | $94 |
| Critical care, first 30-74 minutes | 12 | $2,364 | $197 |
| Muscle electrical test | 19 | $1,306 | $62 |
| Measurement of brain wave activity (eeg), awake and drowsy | 15 | $806 | $54 |
2018: 13 services
| Return visit (30+ min) | 309 | $56,341 | $94 |
| New patient visit (45+ min) | 159 | $23,063 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $11,280 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 93 | $11,257 | $121 |
| Critical care, first 30-74 minutes | 33 | $6,461 | $196 |
| Nerve test | 28 | $5,321 | $190 |
| Nerve test | 14 | $4,094 | $292 |
| Muscle electrical test | 40 | $3,739 | $59 |
| Muscle electrical test | 38 | $3,654 | $91 |
| Measurement of brain wave activity (eeg), awake and drowsy | 22 | $1,218 | $53 |
| Measurement of brain wave activity (eeg), awake and asleep | 19 | $1,057 | $53 |
| Short return visit (20+ min) | 14 | $788 | $56 |
| Measurement of brain wave activity (eeg), in coma or asleep | 12 | $636 | $53 |
2017: 12 services
| Return visit (30+ min) | 259 | $42,074 | $93 |
| New patient visit (45+ min) | 101 | $14,965 | $148 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 99 | $12,204 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $6,954 | $64 |
| Critical care, first 30-74 minutes | 21 | $4,514 | $196 |
| Muscle electrical test | 38 | $4,439 | $91 |
| Nerve test | 19 | $3,697 | $195 |
| Nerve test | 12 | $3,471 | $289 |
| Nerve test | 14 | $3,087 | $221 |
| Muscle electrical test | 22 | $1,739 | $60 |
| Measurement of brain wave activity (eeg), awake and drowsy | 24 | $1,264 | $53 |
| New patient visit (15+ min) | 17 | $1,209 | $71 |
2016: 11 services
| Return visit (30+ min) | 208 | $38,509 | $98 |
| New patient visit (45+ min) | 104 | $15,145 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $14,523 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 111 | $13,581 | $120 |
| Nerve test | 24 | $4,501 | $188 |
| Muscle electrical test | 32 | $3,430 | $90 |
| Muscle electrical test | 23 | $1,612 | $60 |
| Short return visit (20+ min) | 23 | $1,549 | $62 |
| Measurement of brain wave activity (eeg), awake and asleep | 19 | $947 | $50 |
| Measurement of brain wave activity (eeg), awake and drowsy | 17 | $943 | $52 |
| New patient visit (15+ min) | 13 | $847 | $65 |
2015: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 64 | $13,696 | $65 |
| Return visit (30+ min) | 74 | $9,705 | $101 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 70 | $8,537 | $120 |
| New patient visit (45+ min) | 51 | $7,782 | $153 |
| Muscle electrical test | 23 | $3,157 | $90 |
| Nerve test | 16 | $3,088 | $193 |
| Short return visit (20+ min) | 35 | $2,682 | $69 |
| Muscle electrical test | 12 | $1,012 | $60 |
| Measurement of brain wave activity (eeg), awake and drowsy | 17 | $895 | $53 |
| Measurement of brain wave activity (eeg), awake and asleep | 11 | $685 | $53 |
Medicaid work
$3,739 in 2024
Medicaid paid $3,739 for 558 billed services this clinician did in 2024, up to 48 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 410 | $2,437 |
| New patient visit (45+ min) | 68 | $766 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 24 | $323 |
| Short return visit (20+ min) | 56 | $214 |
| 2024 | 558 | 4 | 48 | $3,739 |
| 2023 | 598 | 5 | 100 | $3,482 |
| 2022 | 782 | 4 | 88 | $2,429 |
| 2021 | 795 | 3 | 74 | $1,173 |
| 2020 | 523 | 3 | 59 | $293 |
| 2019 | 751 | 2 | 81 | $994 |
| 2018 | 592 | 2 | 51 | $392 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 478 | $1,747 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 41 | $814 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 20 | $540 |
| New patient visit (45+ min) | 42 | $274 |
| 1ST HOSP IP/OBS HIGH 75 | 17 | $108 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 83 | $922 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 42 | $755 |
| Return visit (30+ min) | 586 | $683 |
| New patient visit (45+ min) | 71 | $69 |
2021
| Return visit (30+ min) | 713 | $841 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $227 |
| New patient visit (45+ min) | 70 | $105 |
2020
| Return visit (30+ min) | 390 | $217 |
| New patient visit (45+ min) | 98 | $76 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 35 | $0 |
2019
| Return visit (30+ min) | 634 | $729 |
| New patient visit (45+ min) | 117 | $265 |
2018
| Return visit (30+ min) | 528 | $392 |
| New patient visit (45+ min) | 64 | $0 |
Drugs they prescribed that Part D paid
$548,072
Pharmacies billed $548,072 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (33 of 1,537) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
1,443 generic and fewer than 11 brand-name prescriptions · $548,072 in drug cost · 29 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xcopri | 16 | $24,401 | $1,525 |
| Zonisade | 13 | $15,099 | $1,161 |
| Lacosamide | 55 | $9,714 | $177 |
| Gabapentin | 162 | $7,562 | $47 |
| Levetiracetam | 95 | $4,305 | $45 |
See all 30 drugs
| Xcopri | 16 | $24,401 | $1,525 |
| Zonisade | 13 | $15,099 | $1,161 |
| Lacosamide | 55 | $9,714 | $177 |
| Gabapentin | 162 | $7,562 | $47 |
| Levetiracetam | 95 | $4,305 | $45 |
| Carbidopa-Levodopa | 114 | $3,717 | $33 |
| Memantine | 128 | $3,253 | $25 |
| Rasagiline Mesylate | 11 | $2,615 | $238 |
| Carbidopa-Levodopa Er | 41 | $2,142 | $52 |
| Nortriptyline | 30 | $1,500 | $50 |
| Duloxetine | 50 | $1,379 | $28 |
| Pregabalin | 41 | $1,102 | $27 |
| Divalproex | 13 | $1,046 | $80 |
| Primidone | 34 | $1,024 | $30 |
| Risperidone | 17 | $901 | $53 |
| Pramipexole Dihydrochloride | 45 | $879 | $20 |
| Donepezil | 71 | $856 | $12 |
| Mirtazapine | 45 | $788 | $18 |
| Quetiapine | 11 | $735 | $67 |
| Oxcarbazepine | 13 | $622 | $48 |
| Clopidogrel | 55 | $566 | $10 |
| Amitriptyline | 33 | $422 | $13 |
| Acetaminophen-Codeine | 17 | $331 | $19 |
| Topiramate | 34 | $329 | $10 |
| Ropinirole | 17 | $324 | $19 |
| Propranolol | 11 | $244 | $22 |
| Atorvastatin | 30 | $212 | $7 |
| Clonazepam | 14 | $201 | $14 |
| Fluoxetine | 17 | $150 | $9 |
| Trazodone | 17 | $73 | $4 |
Year by year
| 2024 | 1,537 | 427 | 2% (33) | None | $548,072 |
| 2023 | 2,143 | 489 | 3% (61) | 7% | $481,568 |
| 2022 | 2,609 | 517 | 2% (46) | None | $380,316 |
| 2021 | 3,521 | 574 | 2% (67) | 7% | $528,182 |
| 2020 | 3,132 | 537 | 2% (68) | 7% | $525,407 |
| 2019 | 3,367 | 522 | 2% (57) | 7% | $553,927 |
| 2018 | 3,118 | 520 | 2% (63) | 7% | $430,613 |
| 2017 | 2,941 | 474 | 3% (78) | None | $282,059 |
| 2016 | 2,199 | 379 | 2% (40) | None | $225,591 |
| 2015 | 589 | 172 | None | 11% | $53,205 |
| 2014 | 151 | 25 | 0% (0) | 19% | $86,533 |
| 2013 | 62 | 14 | None | 21% | $44,996 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 45 drugs
| Nuplazid | Parkinson's psychosis | 23 | $73,959 | $3,216 |
| Lacosamide | None | 48 | $22,225 | $463 |
| Xcopri | None | 13 | $15,885 | $1,222 |
| Fycompa | None | 13 | $13,266 | $1,020 |
| Aimovig | Migraine | 15 | $11,498 | $767 |
| Emgality | Migraine | 14 | $10,682 | $763 |
| Levetiracetam | None | 154 | $10,294 | $67 |
| Carbidopa-Levodopa | None | 150 | $9,941 | $66 |
| Gabapentin | None | 245 | $9,828 | $40 |
| Memantine | None | 157 | $8,764 | $56 |
| Rasagiline Mesylate | None | 11 | $7,903 | $718 |
| Duloxetine | None | 97 | $4,506 | $46 |
| Donepezil | None | 135 | $4,398 | $33 |
| Rivastigmine | None | 11 | $4,056 | $369 |
| Entacapone | None | 16 | $3,504 | $219 |
| Ropinirole | None | 28 | $3,109 | $111 |
| Carbidopa-Levodopa Er | None | 42 | $2,981 | $71 |
| Pramipexole Dihydrochloride | None | 24 | $2,097 | $87 |
| Oxcarbazepine | None | 13 | $1,827 | $141 |
| Carbamazepine | None | 30 | $1,821 | $61 |
| Topiramate | None | 68 | $1,676 | $25 |
| Pregabalin | None | 34 | $1,569 | $46 |
| Mirtazapine | None | 48 | $1,366 | $28 |
| Phenobarbital | None | 19 | $1,236 | $65 |
| Nortriptyline | None | 31 | $1,209 | $39 |
| Clopidogrel | None | 31 | $895 | $29 |
| Propranolol | None | 20 | $868 | $43 |
| Amitriptyline | None | 35 | $838 | $24 |
| Baclofen | None | 19 | $812 | $43 |
| Risperidone | None | 22 | $787 | $36 |
| Quetiapine | None | 20 | $642 | $32 |
| Primidone | None | 26 | $636 | $24 |
| Lamotrigine | None | 19 | $634 | $33 |
| Eszopiclone | None | 11 | $610 | $55 |
| Fluoxetine | None | 28 | $550 | $20 |
| Clonazepam | None | 36 | $538 | $15 |
| Escitalopram | None | 12 | $408 | $34 |
| Trazodone | None | 23 | $407 | $18 |
| Phenytoin Sodium Extended | None | 11 | $353 | $32 |
| Acetaminophen-Codeine | None | 27 | $310 | $11 |
| Atorvastatin | None | 14 | $276 | $20 |
| Sumatriptan | None | 19 | $261 | $14 |
| Tramadol | None | 19 | $217 | $11 |
| Zolpidem | None | 24 | $188 | $8 |
| Lorazepam | None | 11 | $79 | $7 |
2022: 54 drugs
| Nuplazid | Parkinson's psychosis | 23 | $59,073 | $2,568 |
| Vimpat | None | 27 | $43,022 | $1,593 |
| Rasagiline Mesylate | None | 28 | $24,618 | $879 |
| Namzaric | None | 11 | $18,982 | $1,726 |
| Xcopri | None | 14 | $16,310 | $1,165 |
| Memantine | None | 190 | $15,614 | $82 |
| Nurtec Odt | None | 12 | $14,075 | $1,173 |
| Gabapentin | None | 318 | $9,905 | $31 |
| Carbidopa-Levodopa | None | 180 | $9,304 | $52 |
| Levetiracetam | None | 149 | $9,276 | $62 |
| Emgality | Migraine | 12 | $8,148 | $679 |
| Duloxetine | None | 106 | $7,788 | $73 |
| Aimovig | Migraine | 11 | $7,709 | $701 |
| Emgality | Migraine | 11 | $6,978 | $634 |
| Entacapone | None | 22 | $5,982 | $272 |
| Memantine Hcl Er | None | 15 | $5,950 | $397 |
| Lacosamide | None | 22 | $5,852 | $266 |
| Carbidopa-Levodopa Er | None | 71 | $5,160 | $73 |
| Rivastigmine | None | 11 | $3,878 | $353 |
| Donepezil | None | 130 | $2,732 | $21 |
| Mirtazapine | None | 91 | $2,582 | $28 |
| Nortriptyline | None | 59 | $1,721 | $29 |
| Propranolol | None | 33 | $1,673 | $51 |
| Carbamazepine | None | 28 | $1,639 | $59 |
| Amitriptyline | None | 56 | $1,614 | $29 |
| Oxcarbazepine | None | 20 | $1,539 | $77 |
| Baclofen | None | 30 | $1,500 | $50 |
| Topiramate | None | 70 | $1,376 | $20 |
| Amantadine | None | 14 | $1,324 | $95 |
| Pregabalin | None | 32 | $1,168 | $36 |
| Clopidogrel | None | 45 | $1,083 | $24 |
| Ropinirole | None | 30 | $1,069 | $36 |
| Quetiapine | None | 46 | $1,058 | $23 |
| Phenytoin Sodium Extended | None | 26 | $998 | $38 |
| Divalproex | None | 18 | $971 | $54 |
| Trazodone | None | 35 | $922 | $26 |
| Divalproex Sodium Er | None | 11 | $806 | $73 |
| Primidone | None | 26 | $755 | $29 |
| Fluoxetine | None | 57 | $731 | $13 |
| Lamotrigine | None | 29 | $707 | $24 |
| Atorvastatin | None | 36 | $647 | $18 |
| Pramipexole Dihydrochloride | None | 36 | $624 | $17 |
| Risperidone | None | 44 | $441 | $10 |
| Sumatriptan | None | 29 | $437 | $15 |
| Zonisamide | None | 11 | $406 | $37 |
| Acetaminophen-Codeine | None | 24 | $286 | $12 |
| Verapamil | None | 14 | $252 | $18 |
| Tramadol | None | 14 | $248 | $18 |
| Trihexyphenidyl | None | 12 | $245 | $20 |
| Escitalopram | None | 11 | $214 | $19 |
| Clonazepam | None | 22 | $171 | $8 |
| Sertraline | None | 15 | $163 | $11 |
| Phenytoin | None | 12 | $123 | $10 |
| Lorazepam | None | 14 | $63 | $4 |
2021: 60 drugs
| Vimpat | None | 88 | $110,915 | $1,260 |
| Rasagiline Mesylate | None | 36 | $23,539 | $654 |
| Namzaric | None | 14 | $22,492 | $1,607 |
| Aimovig | Migraine | 28 | $18,816 | $672 |
| Emgality | Migraine | 24 | $15,428 | $643 |
| Memantine | None | 215 | $15,371 | $71 |
| Fycompa | None | 19 | $13,565 | $714 |
| Carbidopa-Levodopa | None | 183 | $11,756 | $64 |
| Levetiracetam | None | 207 | $10,924 | $53 |
| Neupro | None | 12 | $10,873 | $906 |
| Gabapentin | None | 490 | $9,907 | $20 |
| Donepezil | None | 175 | $8,729 | $50 |
| Memantine Hcl Er | None | 30 | $8,389 | $280 |
| Duloxetine | None | 173 | $7,884 | $46 |
| Carbidopa-Levodopa Er | None | 77 | $6,324 | $82 |
| Entacapone | None | 23 | $5,643 | $245 |
| Rivastigmine | None | 11 | $4,180 | $380 |
| Rivastigmine | None | 26 | $3,718 | $143 |
| Pyridostigmine | None | 11 | $3,271 | $297 |
| Nortriptyline | None | 107 | $2,987 | $28 |
| Carbamazepine Er | None | 19 | $2,301 | $121 |
| Carbamazepine | None | 33 | $1,982 | $60 |
| Propranolol | None | 41 | $1,978 | $48 |
| Phenytoin Sodium Extended | None | 41 | $1,513 | $37 |
| Pregabalin | None | 52 | $1,496 | $29 |
| Topiramate | None | 81 | $1,490 | $18 |
| Mirtazapine | None | 93 | $1,425 | $15 |
| Galantamine Hbr | None | 15 | $1,406 | $94 |
| Amitriptyline | None | 72 | $1,406 | $20 |
| Phenobarbital | None | 19 | $1,216 | $64 |
| Clopidogrel | None | 66 | $1,197 | $18 |
| Amantadine | None | 12 | $1,177 | $98 |
| Pramipexole Dihydrochloride | None | 59 | $1,165 | $20 |
| Ropinirole | None | 38 | $1,086 | $29 |
| Baclofen | None | 38 | $1,056 | $28 |
| Divalproex | None | 31 | $1,031 | $33 |
| Fluoxetine | None | 69 | $1,028 | $15 |
| Quetiapine | None | 71 | $869 | $12 |
| Sumatriptan | None | 50 | $798 | $16 |
| Acetaminophen-Codeine | None | 32 | $774 | $24 |
| Zonisamide | None | 16 | $774 | $48 |
| Lamotrigine | None | 32 | $742 | $23 |
| Midodrine | None | 13 | $691 | $53 |
| Divalproex Sodium Er | None | 14 | $665 | $47 |
| Oxcarbazepine | None | 14 | $640 | $46 |
| Atorvastatin | None | 27 | $588 | $22 |
| Risperidone | None | 40 | $541 | $14 |
| Trazodone | None | 36 | $474 | $13 |
| Verapamil | None | 19 | $425 | $22 |
| Trihexyphenidyl | None | 11 | $314 | $29 |
| Primidone | None | 12 | $296 | $25 |
| Clonazepam | None | 42 | $274 | $7 |
| Meclizine | None | 21 | $261 | $12 |
| Tramadol | None | 22 | $259 | $12 |
| Hydrocodone-Acetaminophen | None | 13 | $202 | $16 |
| Sertraline | None | 25 | $200 | $8 |
| Lorazepam | None | 23 | $160 | $7 |
| Phenytoin | None | 12 | $145 | $12 |
| Ibuprofen | None | 12 | $122 | $10 |
| Zolpidem | None | 13 | $37 | $3 |
2020: 53 drugs
| Tecfidera | None | 11 | $85,482 | $7,771 |
| Vimpat | None | 52 | $80,202 | $1,542 |
| Rasagiline Mesylate | None | 39 | $34,409 | $882 |
| Namzaric | None | 23 | $33,760 | $1,468 |
| Aimovig | Migraine | 21 | $13,165 | $627 |
| Memantine Hcl Er | None | 41 | $12,509 | $305 |
| Memantine | None | 229 | $11,793 | $51 |
| Emgality | Migraine | 19 | $11,616 | $611 |
| Carbidopa-Levodopa | None | 165 | $9,139 | $55 |
| Gabapentin | None | 420 | $8,576 | $20 |
| Donepezil | None | 182 | $8,253 | $45 |
| Entacapone | None | 26 | $7,508 | $289 |
| Rivastigmine | None | 18 | $7,420 | $412 |
| Levetiracetam | None | 179 | $7,358 | $41 |
| Carbidopa-Levodopa Er | None | 66 | $4,707 | $71 |
| Duloxetine | None | 116 | $4,230 | $36 |
| Rivastigmine | None | 23 | $3,748 | $163 |
| Carbamazepine | None | 42 | $3,593 | $86 |
| Carbamazepine Er | None | 31 | $3,296 | $106 |
| Nortriptyline | None | 78 | $2,807 | $36 |
| Divalproex | None | 60 | $1,944 | $32 |
| Pregabalin | None | 41 | $1,907 | $47 |
| Phenytoin Sodium Extended | None | 44 | $1,525 | $35 |
| Sumatriptan | None | 34 | $1,456 | $43 |
| Baclofen | None | 45 | $1,177 | $26 |
| Pramipexole Dihydrochloride | None | 38 | $1,176 | $31 |
| Donepezil Hcl Odt | None | 11 | $1,163 | $106 |
| Mirtazapine | None | 63 | $1,110 | $18 |
| Amitriptyline | None | 50 | $1,108 | $22 |
| Fluoxetine | None | 87 | $1,034 | $12 |
| Clopidogrel | None | 74 | $1,022 | $14 |
| Topiramate | None | 61 | $988 | $16 |
| Phenobarbital | None | 14 | $899 | $64 |
| Trazodone | None | 42 | $778 | $19 |
| Ropinirole | None | 28 | $723 | $26 |
| Propranolol | None | 20 | $531 | $27 |
| Verapamil | None | 23 | $502 | $22 |
| Atorvastatin | None | 42 | $491 | $12 |
| Lamotrigine | None | 28 | $470 | $17 |
| Quetiapine | None | 43 | $428 | $10 |
| Acetaminophen-Codeine | None | 33 | $404 | $12 |
| Divalproex Sodium Er | None | 13 | $394 | $30 |
| Trihexyphenidyl | None | 14 | $351 | $25 |
| Primidone | None | 14 | $301 | $22 |
| Simvastatin | None | 14 | $202 | $14 |
| Clonazepam | None | 30 | $200 | $7 |
| Benztropine Mesylate | None | 17 | $198 | $12 |
| Risperidone | None | 21 | $178 | $8 |
| Tramadol | None | 29 | $153 | $5 |
| Meclizine | None | 12 | $145 | $12 |
| Phenytoin | None | 12 | $142 | $12 |
| Sertraline | None | 15 | $123 | $8 |
| Lorazepam | None | 23 | $95 | $4 |
2019: 56 drugs
| Vimpat | None | 52 | $70,351 | $1,353 |
| Glatiramer Acetate | None | 13 | $66,080 | $5,083 |
| Rasagiline Mesylate | None | 46 | $34,121 | $742 |
| Namzaric | None | 23 | $29,213 | $1,270 |
| Eliquis | None | 22 | $21,416 | $973 |
| Memantine | None | 233 | $19,830 | $85 |
| Memantine Hcl Er | None | 47 | $18,107 | $385 |
| Entacapone | None | 33 | $14,490 | $439 |
| Fycompa | None | 13 | $12,872 | $990 |
| Carbidopa-Levodopa | None | 209 | $11,763 | $56 |
| Gabapentin | None | 410 | $10,275 | $25 |
| Donepezil | None | 229 | $9,756 | $43 |
| Aimovig | Migraine | 14 | $9,376 | $670 |
| Levetiracetam | None | 186 | $7,523 | $40 |
| Rivastigmine | None | 14 | $6,754 | $482 |
| Carbidopa-Levodopa Er | None | 98 | $5,467 | $56 |
| Duloxetine | None | 110 | $5,085 | $46 |
| Carbamazepine | None | 42 | $3,237 | $77 |
| Carbamazepine Er | None | 17 | $3,082 | $181 |
| Nortriptyline | None | 102 | $2,441 | $24 |
| Rivastigmine | None | 14 | $2,351 | $168 |
| Divalproex | None | 48 | $2,290 | $48 |
| Lidocaine | None | 14 | $2,225 | $159 |
| Trazodone | None | 73 | $1,799 | $25 |
| Pramipexole Dihydrochloride | None | 34 | $1,598 | $47 |
| Fluoxetine | None | 123 | $1,371 | $11 |
| Mirtazapine | None | 65 | $1,230 | $19 |
| Amitriptyline | None | 30 | $1,205 | $40 |
| Phenobarbital | None | 26 | $1,144 | $44 |
| Baclofen | None | 61 | $1,120 | $18 |
| Phenytoin Sodium Extended | None | 39 | $1,097 | $28 |
| Clopidogrel | None | 67 | $937 | $14 |
| Ropinirole | None | 31 | $884 | $29 |
| Topiramate | None | 42 | $845 | $20 |
| Donepezil Hcl Odt | None | 16 | $800 | $50 |
| Propranolol | None | 18 | $781 | $43 |
| Atorvastatin | None | 58 | $762 | $13 |
| Verapamil | None | 33 | $729 | $22 |
| Sumatriptan | None | 24 | $504 | $21 |
| Quetiapine | None | 49 | $455 | $9 |
| Trihexyphenidyl | None | 22 | $415 | $19 |
| Primidone | None | 29 | $410 | $14 |
| Lamotrigine | None | 17 | $396 | $23 |
| Ranitidine | None | 13 | $376 | $29 |
| Risperidone | None | 39 | $297 | $8 |
| Lorazepam | None | 34 | $196 | $6 |
| Acetaminophen-Codeine | None | 22 | $188 | $9 |
| Paroxetine | None | 11 | $176 | $16 |
| Simvastatin | None | 21 | $168 | $8 |
| Tramadol | None | 32 | $152 | $5 |
| Sertraline | None | 17 | $151 | $9 |
| Prednisone | None | 11 | $112 | $10 |
| Clonazepam | None | 21 | $75 | $4 |
| Naproxen | None | 11 | $70 | $6 |
| Amlodipine Besylate | None | 14 | $67 | $5 |
| Alprazolam | None | 17 | $49 | $3 |
2018: 54 drugs
| Tecfidera | 12 | $79,498 | $6,625 |
| Vimpat | 46 | $65,768 | $1,430 |
| Donepezil | 258 | $23,533 | $91 |
| Rasagiline Mesylate | 31 | $19,809 | $639 |
| Memantine Hcl Er | 41 | $19,342 | $472 |
| Namzaric | 21 | $19,117 | $910 |
| Namenda Xr | 26 | $17,047 | $656 |
| Lyrica | 31 | $16,298 | $526 |
| Entacapone | 34 | $16,031 | $472 |
| Memantine | 182 | $14,399 | $79 |
| Carbidopa-Levodopa | 227 | $13,545 | $60 |
| Gabapentin | 428 | $9,848 | $23 |
| Duloxetine | 121 | $7,203 | $60 |
| Levetiracetam | 144 | $6,500 | $45 |
| Carbidopa-Levodopa Er | 86 | $5,203 | $61 |
| Carbamazepine | 29 | $4,570 | $158 |
| Carbamazepine Er | 22 | $3,464 | $157 |
| Rivastigmine | 21 | $3,198 | $152 |
| Pramipexole Dihydrochloride | 47 | $3,094 | $66 |
| Fluoxetine | 90 | $2,626 | $29 |
| Propranolol | 44 | $2,381 | $54 |
| Nortriptyline | 128 | $2,363 | $18 |
| Divalproex | 40 | $1,759 | $44 |
| Baclofen | 44 | $1,294 | $29 |
| Ropinirole | 28 | $1,207 | $43 |
| Phenobarbital | 26 | $1,071 | $41 |
| Phenytoin Sodium Extended | 44 | $1,042 | $24 |
| Quetiapine | 57 | $907 | $16 |
| Topiramate | 38 | $859 | $23 |
| Amitriptyline | 22 | $830 | $38 |
| Lamotrigine | 23 | $704 | $31 |
| Clopidogrel | 49 | $676 | $14 |
| Benztropine Mesylate | 23 | $567 | $25 |
| Donepezil Hcl Odt | 11 | $555 | $50 |
| Risperidone | 25 | $518 | $21 |
| Atorvastatin | 30 | $505 | $17 |
| Trihexyphenidyl | 15 | $433 | $29 |
| Primidone | 24 | $421 | $18 |
| Mirtazapine | 30 | $371 | $12 |
| Sumatriptan | 24 | $316 | $13 |
| Verapamil | 18 | $298 | $17 |
| Clonazepam | 30 | $275 | $9 |
| Zonisamide | 14 | $260 | $19 |
| Acetaminophen-Codeine | 26 | $242 | $9 |
| Temazepam | 12 | $242 | $20 |
| Trazodone | 34 | $232 | $7 |
| Sertraline | 23 | $223 | $10 |
| Simvastatin | 28 | $172 | $6 |
| Tramadol | 33 | $172 | $5 |
| Naproxen | 12 | $118 | $10 |
| Lisinopril | 13 | $98 | $8 |
| Lorazepam | 28 | $95 | $3 |
| Zolpidem | 12 | $60 | $5 |
| Alprazolam | 14 | $30 | $2 |
2017: 51 drugs
| Namenda Xr | 64 | $44,871 | $701 |
| Donepezil | 324 | $24,693 | $76 |
| Nuedexta | 14 | $20,030 | $1,431 |
| Memantine | 161 | $18,778 | $117 |
| Vimpat | 23 | $17,763 | $772 |
| Lyrica | 21 | $13,751 | $655 |
| Namzaric | 20 | $12,660 | $633 |
| Entacapone | 22 | $10,070 | $458 |
| Carbidopa-Levodopa | 219 | $9,767 | $45 |
| Duloxetine | 115 | $8,283 | $72 |
| Gabapentin | 467 | $8,166 | $17 |
| Carbamazepine | 25 | $5,090 | $204 |
| Levetiracetam | 94 | $5,013 | $53 |
| Aspirin-Dipyridamole Er | 12 | $4,422 | $369 |
| Carbidopa-Levodopa Er | 99 | $3,585 | $36 |
| Rivastigmine | 19 | $3,192 | $168 |
| Fluoxetine | 87 | $1,976 | $23 |
| Propranolol | 28 | $1,852 | $66 |
| Nortriptyline | 104 | $1,452 | $14 |
| Carbamazepine Er | 13 | $1,231 | $95 |
| Divalproex | 43 | $1,227 | $29 |
| Ropinirole | 21 | $1,095 | $52 |
| Phenytoin Sodium Extended | 33 | $1,028 | $31 |
| Quetiapine | 77 | $826 | $11 |
| Baclofen | 31 | $646 | $21 |
| Lamotrigine | 21 | $629 | $30 |
| Pramipexole Dihydrochloride | 31 | $591 | $19 |
| Clopidogrel | 44 | $516 | $12 |
| Amitriptyline | 17 | $438 | $26 |
| Primidone | 24 | $379 | $16 |
| Olanzapine | 16 | $376 | $24 |
| Topiramate | 30 | $339 | $11 |
| Benztropine Mesylate | 26 | $323 | $12 |
| Sumatriptan | 24 | $318 | $13 |
| Trihexyphenidyl | 17 | $293 | $17 |
| Acetaminophen-Codeine | 37 | $287 | $8 |
| Tramadol | 38 | $265 | $7 |
| Atorvastatin | 16 | $263 | $16 |
| Trazodone | 25 | $180 | $7 |
| Meclizine | 14 | $162 | $12 |
| Clonazepam | 33 | $161 | $5 |
| Simvastatin | 36 | $160 | $4 |
| Verapamil | 14 | $137 | $10 |
| Citalopram Hbr | 18 | $112 | $6 |
| Prednisone | 16 | $108 | $7 |
| Zolpidem | 18 | $88 | $5 |
| Risperidone | 12 | $79 | $7 |
| Amlodipine Besylate | 15 | $70 | $5 |
| Lorazepam | 14 | $60 | $4 |
| Alprazolam | 21 | $50 | $2 |
| Lisinopril | 13 | $35 | $3 |
2016: 41 drugs
| Tecfidera | 11 | $66,555 | $6,050 |
| Namenda Xr | 54 | $23,640 | $438 |
| Vimpat | 14 | $15,525 | $1,109 |
| Nuedexta | 15 | $12,222 | $815 |
| Memantine | 60 | $10,436 | $174 |
| Lyrica | 24 | $9,920 | $413 |
| Gabapentin | 378 | $8,332 | $22 |
| Azilect | 11 | $6,844 | $622 |
| Carbidopa-Levodopa | 207 | $6,794 | $33 |
| Donepezil | 241 | $6,722 | $28 |
| Duloxetine | 68 | $5,312 | $78 |
| Levetiracetam | 107 | $4,414 | $41 |
| Entacapone | 13 | $3,851 | $296 |
| Rivastigmine | 23 | $3,389 | $147 |
| Carbamazepine | 17 | $2,730 | $161 |
| Carbidopa-Levodopa Er | 85 | $1,981 | $23 |
| Propranolol | 39 | $1,971 | $51 |
| Lidocaine | 12 | $1,754 | $146 |
| Fluoxetine | 81 | $1,255 | $15 |
| Nortriptyline | 72 | $1,088 | $15 |
| Divalproex | 29 | $964 | $33 |
| Topiramate | 61 | $937 | $15 |
| Ropinirole | 18 | $865 | $48 |
| Baclofen | 23 | $707 | $31 |
| Quetiapine | 37 | $520 | $14 |
| Phenytoin Sodium Extended | 14 | $505 | $36 |
| Sumatriptan | 30 | $396 | $13 |
| Lamotrigine | 26 | $387 | $15 |
| Primidone | 22 | $377 | $17 |
| Amitriptyline | 14 | $311 | $22 |
| Clopidogrel | 29 | $213 | $7 |
| Pramipexole Dihydrochloride | 16 | $198 | $12 |
| Acetaminophen-Codeine | 21 | $189 | $9 |
| Simvastatin | 31 | $189 | $6 |
| Atorvastatin | 14 | $163 | $12 |
| Sertraline | 13 | $129 | $10 |
| Clonazepam | 21 | $99 | $5 |
| Citalopram Hbr | 16 | $93 | $6 |
| Tramadol | 14 | $72 | $5 |
| Lorazepam | 12 | $69 | $6 |
| Prednisone | 11 | $61 | $6 |
2015: 13 drugs
| Namenda Xr | 16 | $5,191 | $324 |
| Riluzole | 14 | $4,303 | $307 |
| Duloxetine | 17 | $3,296 | $194 |
| Gabapentin | 86 | $1,733 | $20 |
| Carbamazepine | 12 | $1,225 | $102 |
| Carbidopa-Levodopa | 35 | $1,192 | $34 |
| Levetiracetam | 32 | $826 | $26 |
| Donepezil | 55 | $558 | $10 |
| Nortriptyline | 29 | $407 | $14 |
| Topiramate | 13 | $185 | $14 |
| Amitriptyline | 11 | $154 | $14 |
| Fluoxetine | 23 | $116 | $5 |
| Prednisone | 11 | $113 | $10 |
2014: 6 drugs
| Aubagio | 13 | $61,140 | $4,703 |
| Ampyra | 13 | $21,146 | $1,627 |
| Gabapentin | 14 | $556 | $40 |
| Levetiracetam | 19 | $432 | $23 |
| Zonisamide | 11 | $304 | $28 |
| Sumatriptan | 11 | $243 | $22 |
2013: 1 drug
| Aubagio | 11 | $42,388 | $3,853 |
Money from drug and device companies
$1,121 in 2025
| 2025 | 24 | 37 | None | $1,121 |
| 2024 | 18 | 36 | None | $1,088 |
| 2023 | 16 | 28 | None | $794 |
| 2022 | 17 | 31 | None | $688 |
| 2021 | 21 | 34 | None | $1,286 |
| 2020 | 13 | 17 | None | $387 |
| 2019 | 15 | 22 | $16 | $642 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alexion Pharmaceuticals | Ultomiris | $119 | 4 payments
|
| Lilly USA | Zepbound | $114 | 4 payments
|
| Ucb | Briviact | $103 | 3 payments
|
| Octapharma USA | Panzyga | $70 | 2 payments
|
| MDD US Operations | None | $69 | 3 payments
|
| Lundbeck | Vyepti | $69 | 2 payments
|
See all 37 published payments
| Axsome Therapeutics | Meals · 2025-12-10 | Symbravo | $30 |
| Lilly USA | Meals · 2025-12-04 | None | $35 |
| Alexion Pharmaceuticals | Meals · 2025-11-13 | Ultomiris | $29 |
| TG Therapeutics | Meals · 2025-10-29 | Briumvi | $37 |
| ANI Pharmaceuticals | Meals · 2025-10-15 | Purified Cortrophin Gel | $19 |
| Xeris Pharmaceuticals | Meals · 2025-10-08 | Keveyis | $22 |
| Argenx US | Meals · 2025-10-02 | Vyvgart Hytrulo | $16 |
| Merz Pharmaceuticals | Meals · 2025-09-25 | Xeomin | $36 |
| Octapharma USA | Meals · 2025-09-03 | Panzyga | $21 |
| Abbvie | Meals · 2025-08-29 | Vyalev | $22 |
| Lilly USA | Meals · 2025-08-26 | Zepbound | $31 |
| Lilly USA | Meals · 2025-08-06 | Zepbound | $20 |
| Alexion Pharmaceuticals | Meals · 2025-08-06 | Ultomiris | $30 |
| Catalyst Pharmaceuticals | Meals · 2025-07-31 | Firdapse | $49 |
| Grifols USA | Meals · 2025-07-30 | Gamunex-C | $25 |
| Biogen | Meals · 2025-07-23 | Tysabri | $29 |
| Avadel CNS Pharmaceuticals | Meals · 2025-07-16 | Lumryz | $35 |
| Alexion Pharmaceuticals | Meals · 2025-07-03 | Ultomiris | $29 |
| LivaNova USA | Meals · 2025-06-25 | Vns Therapy Sentiva Model 1000 Generator | $28 |
| Ucb | Meals · 2025-06-18 | Fintepla | $31 |
| MDD US Operations | Meals · 2025-06-12 | None | $19 |
| Otsuka America Pharmaceutical | Meals · 2025-06-04 | Rexulti | $27 |
| Lilly USA | Meals · 2025-05-22 | Zepbound | $29 |
| Ucb | Meals · 2025-05-21 | Briviact | $35 |
| Lundbeck | Meals · 2025-05-14 | Vyepti | $35 |
| MDD US Operations | Meals · 2025-05-08 | None | $28 |
| Octapharma USA | Meals · 2025-04-30 | Panzyga | $49 |
| Harmony Biosciences | Meals · 2025-04-23 | Wakix | $35 |
| Biogen | Meals · 2025-04-17 | Vumerity | $29 |
| ACADIA Pharmaceuticals | Meals · 2025-04-17 | Nuplazid | $33 |
| Lundbeck | Meals · 2025-03-20 | Vyepti | $34 |
| MDD US Operations | Meals · 2025-03-06 | None | $23 |
| Ucb | Meals · 2025-02-27 | Briviact | $37 |
| Tanabe Pharma America | Meals · 2025-02-05 | Radicava | $29 |
| Inspire Medical Systems | Meals · 2025-01-31 | Inspire | $51 |
| Alexion Pharmaceuticals | Meals · 2025-01-17 | Ultomiris | $31 |
| Eisai | Meals · 2025-01-15 | Leqembi | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,088
| Inspire Medical Systems | Inspire | $169 | 3 payments
|
| Lundbeck | Vyepti | $168 | 5 payments
|
| Ucb | Briviact | $139 | 4 payments
|
| Abbvie | Ubrelvy | $111 | 4 payments
|
| Biogen | Tysabri | $65 | 3 payments
|
| LivaNova USA | Vns Therapy Sentiva Model 1000 Generator | $54 | 2 payments
|
| Genentech USA | Enspryng | $50 | 2 payments
|
| Eisai | Leqembi | $42 | 2 payments
|
| Jazz Pharmaceuticals | Epidiolex | $39 | 1 payment
|
| Pfizer | Nurtec Odt | $38 | 2 payments
|
| Catalyst Pharmaceuticals | Fycompa | $38 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo Xr | $38 | 1 payment
|
| Lilly USA | Amyvid | $27 | 1 payment
|
| Argenx US | Vyvgart Hytrulo | $26 | 1 payment
|
| Avadel CNS Pharmaceuticals | Lumryz | $25 | 1 payment
|
| Harmony Biosciences | Wakix | $24 | 1 payment
|
| Octapharma USA | Panzyga | $22 | 1 payment
|
| Celgene | Zeposia | $15 | 1 payment
|
2023: $794
| AbbVie | Botox | $213 | 8 payments
|
| Alexion Pharmaceuticals | Ultomiris | $162 | 4 payments
|
| SK Life Science | None | $42 | 2 payments
|
| Harmony Biosciences | Wakix | $42 | 1 payment
|
| Argenx US | Vyvgart | $38 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $33 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo Xr | $33 | 1 payment
|
| Lundbeck | Vyepti | $32 | 1 payment
|
| Catalyst Pharmaceuticals | Fycompa | $31 | 1 payment
|
| Sumitomo Pharma America | Aptiom | $30 | 1 payment
|
| MDD US Operations | None | $29 | 1 payment
|
| Acorda Therapeutics | Inbrija | $26 | 1 payment
|
| Otsuka America Pharmaceutical | Nuedexta | $24 | 1 payment
|
| Jazz Pharmaceuticals | Epidiolex | $20 | 1 payment
|
| Amneal Pharmaceuticals | Rytary | $19 | 1 payment
|
| Lilly USA | Amyvid | $18 | 1 payment
|
2022: $688
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $85 | 5 payments
|
| Neurocrine Biosciences | Ingrezza | $69 | 2 payments
|
| Sunovion Pharmaceuticals | Kynmobi | $68 | 3 payments
|
| Ucb | Briviact | $63 | 2 payments
|
| Abbvie | Botox | $59 | 3 payments
|
| Janssen Pharmaceuticals | Ponvory | $58 | 3 payments
|
| Biogen | Tysabri | $51 | 2 payments
|
| Eisai | Fycompa | $41 | 2 payments
|
| Jazz Pharmaceuticals | Epidiolex | $30 | 1 payment
|
| Lilly USA | Emgality | $27 | 1 payment
|
| LivaNova USA | Vns Therapy Sentiva Model 1000 Generator | $23 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Gattex | $22 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $21 | 1 payment
|
| Harmony Biosciences | Wakix | $20 | 1 payment
|
| Medtronic | Avalus | $19 | 1 payment
|
| MDD US Operations | None | $18 | 1 payment
|
| Scilex Pharmaceuticals | Ztlido | $17 | 1 payment
|
2021: $1,286
| LivaNova USA | Vns - Sentiva | $575 | 2 payments
|
| Teva Pharmaceuticals USA | Austedo | $124 | 7 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $96 | 4 payments
|
| AbbVie | Ubrelvy | $61 | 3 payments
|
| Harmony Biosciences | Wakix | $41 | 1 payment
|
| Eisai | Dayvigo | $39 | 2 payments
|
| Biogen | Aduhelm | $28 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $27 | 1 payment
|
| Ucb | Briviact | $26 | 1 payment
|
| Horizon Therapeutics plc | Uplizna | $26 | 1 payment
|
| MDD US Operations | Apokyn | $25 | 1 payment
|
| Aquestive Therapeutics | Sympazan | $24 | 1 payment
|
| Lilly USA | Emgality | $23 | 1 payment
|
| Merz Pharmaceuticals | Xeomin | $23 | 1 payment
|
| Boston Scientific | General Dbs | $23 | 1 payment
|
| SK Life Science | None | $22 | 1 payment
|
| Sunovion Pharmaceuticals | Kynmobi | $22 | 1 payment
|
| Merck Sharp & Dohme | Belsomra | $22 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $21 | 1 payment
|
| Upsher-Smith Laboratories | Tosymra | $20 | 1 payment
|
| Novartis Pharmaceuticals | Kesimpta | $19 | 1 payment
|
2020: $387
| Allergan | Ubrelvy | $60 | 3 payments
|
| Adamas Pharmaceuticals | Gocovri | $47 | 2 payments
|
| LivaNova USA | Vns Therapy | $39 | 2 payments
|
| Greenwich Biosciences | Epidiolex | $33 | 1 payment
|
| Abbott Laboratories | Infinity Dbs Pulse Generators | $30 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $28 | 1 payment
|
| Biogen | Vumerity | $28 | 1 payment
|
| Lilly USA | Emgality | $26 | 1 payment
|
| Sunovion Pharmaceuticals | Kynmobi | $23 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $20 | 1 payment
|
| SK Life Science | None | $19 | 1 payment
|
| Eisai | Fycompa | $19 | 1 payment
|
| Boston Scientific | General - Dbs | $17 | 1 payment
|
2019: $642
| Ucb | Briviact | $205 | 5 payments
|
| Akcea Therapeutics | Tegsedi | $113 | 1 payment
|
| Eisai | Fycompa | $55 | 3 payments
|
| Bausch Health US | Migranal | $35 | 2 payments
|
| NeuroPace | Rns System | $31 | 1 payment
|
| Resmed | Airfit | $25 | 1 payment
|
| Genzyme | Aubagio | $25 | 1 payment
|
| Greenwich Biosciences | Epidiolex | $24 | 1 payment
|
| Biogen | Tysabri | $24 | 1 payment
|
| Amneal Pharmaceuticals | Rytary | $22 | 1 payment
|
| Lilly USA | Emgality | $19 | 1 payment
|
| AbbVie | Duopa | $17 | 1 payment
|
| Alexion Pharmaceuticals | Soliris | $16 | 1 payment
|
| Acorda Therapeutics | Inbrija | $16 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1891095964
- Licence
- CA A129993California A129993: Current · expires 2027-08-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Neurology (2084N0400X); Federal specialty code 2084N0600X (2084N0600X)
- Mailing address
- 200 Jose Figueres Ave,, Suite 200, San Jose, CA, 95116
- NPI first listed
- 2010-10-23
- NPI last updated
- 2016-12-13
This is when the NPI record was last certified, not a medical board exam.